Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
India

India may buy 50mn Pfizer COVID-19 vaccine doses: Details here

India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
Written by Ramya Patelkhana
May 16, 2021, 01:31 am 3 min read
India may buy 50mn Pfizer COVID-19 vaccine doses: Details here
Credits:
Centre in talks with Pfizer to procure COVID-19 vaccine doses

At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year. Top Indian Government officials have been discussing the availability of vaccines with senior executives at Pfizer over several meetings.

Details
Pfizer's insistence on indemnity seems to be the main hurdle

The current negotiations between the Centre and Pfizer are likely to find a successful conclusion, reported Times of India. However, the main hurdle is Pfizer insisting on indemnity that protects it against any legal action and liabilities in India resulting from any side-effects of its vaccines. But, according to Economic Times, both parties are close to finding a solution to the issue of indemnity.

Centre's move
Demand for vaccines against COVID-19 rising in India

Reports say that Pfizer's vaccine doses against COVID-19 will be available for purchase by the Centre only for its COVID-19 vaccination program. Although the company's vaccines are quite expensive, the government seems to be considering buying them as the demand for expanding the number of COVID-19 vaccines available for the people in the country has increased.

Manufacturing
Pfizer doses for India likely to be produced in Europe

However, the US still does not allow for COVID-19 vaccines being manufactured by Pfizer or Moderna in the country to be exported; it will not permit the exports as long as there is a domestic requirement for the vaccines. Hence, the vaccine manufacturing centers based in Europe are likely to produce the Pfizer vaccines that the Indian Government intends to procure from the company.

The EMA
Vaccines using mRNA technology effective against new Indian variant: EMA

Meanwhile, the European Medicines Agency (EMA) recently said the mRNA vaccines it has authorized—including Pfizer's—can fight against the new Indian coronavirus variant. "EMA is monitoring the data on the Indian variant very closely. We are seeing promising evidence that mRNA vaccines will be able to neutralize this variant," it said. So far, EMA approved Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, and Johnson & Johnson vaccines for Europe.

Vaccine shortage
Many Indian states decide to float global tenders for vaccines

Notably, the development comes at a time when India is running out of vaccines to protect people against COVID-19 as a deadly second wave—amid warnings of a more dangerous third wave—devastates the country. Since there is high demand and an acute shortage of vaccines, at least 10 states have decided to issue global tenders for procuring vaccines from international vaccine makers to inoculate people.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Latest
Pfizer
Indian Government
Coronavirus
COVID-19
COVID-19 Vaccine
Related
Latest
Maserati Cielo convertible to break cover on May 25
Maserati Cielo convertible to break cover on May 25 Auto
5 films that deal with postpartum depression
5 films that deal with postpartum depression Entertainment
French Open, Rafael Nadal vs Novak Djokovic: Rivalry in numbers
French Open, Rafael Nadal vs Novak Djokovic: Rivalry in numbers Sports
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal
Statistical comparison of 'Big Titles' between Djokovic, Federer, and Nadal Sports
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC
Vivo S15 Pro announced with MediaTek Dimensity 8100 SoC Technology
Pfizer
New Omicron sub-variants can trigger new COVID-19 wave: Study
New Omicron sub-variants can trigger new COVID-19 wave: Study World
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine World
'Cautious optimism' after initial Omicron studies; here's what we know
'Cautious optimism' after initial Omicron studies; here's what we know Technology
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 10K+ infections; 301 more deaths
COVID-19: India reports 10K+ infections; 301 more deaths India
More News
Indian Government
Centre stops EV makers from launching new vehicles
Centre stops EV makers from launching new vehicles Auto
World Consumer Rights Day: History and 6 basic consumer rights
World Consumer Rights Day: History and 6 basic consumer rights Lifestyle
LIC files papers for India's biggest IPO
LIC files papers for India's biggest IPO India
Government holds heated meet with Twitter, Facebook, Google: Report
Government holds heated meet with Twitter, Facebook, Google: Report India
In a first, Assam to launch leopard census from Monday
In a first, Assam to launch leopard census from Monday India
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19
COVID-19: India reports 2,364 fresh cases, 10 more deaths
COVID-19: India reports 2,364 fresh cases, 10 more deaths India
COVID-19: India reports 1,829 new cases, 33 more fatalities
COVID-19: India reports 1,829 new cases, 33 more fatalities India
COVID-19: India reports 1,569 new cases, 19 more deaths
COVID-19: India reports 1,569 new cases, 19 more deaths India
COVID-19: India logs 2,202 new cases; 27 more deaths
COVID-19: India logs 2,202 new cases; 27 more deaths India
COVID-19: India logs 2,487 fresh cases, 13 more fatalities
COVID-19: India logs 2,487 fresh cases, 13 more fatalities India
More News
COVID-19 Vaccine
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
More News
Related
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022